Exact Sciences Corporation
36
7
11
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.9%
5 terminated/withdrawn out of 36 trials
80.0%
-6.6% vs industry average
0%
0 trials in Phase 3/4
25%
5 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (36)
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Role: lead
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Role: collaborator
Falcon Real World Evidence Registry
Role: lead
The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
Role: collaborator
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Role: lead
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
Role: lead
Informed Choice - Compass
Role: lead
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Role: lead
Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality
Role: lead
First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer
Role: lead
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Role: lead
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
Role: collaborator
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
Role: lead
Stool Sample Collection Study
Role: collaborator
Home Usability Study of the SARS-CoV-2 (COVID-19) Test
Role: lead
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
Role: lead
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"
Role: lead
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
Role: collaborator
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Role: lead
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01
Role: lead